Factors associated with SARS-CoV-2 antibody titers and prognosis of breakthrough infection in hemodialysis patients.
Masataro TodaAyumi YoshifujiKan KikuchiMasayoshi KoinumaMotoaki KomatsuKentaro FujiiAi KatoTakahide KikuchiAtsushi NakazawaMunekazu RyuzakiPublished in: Clinical and experimental nephrology (2022)
Vaccines improved the severity of COVID-19 and hospitalization period of breakthrough infection in HDP, although HDP, especially in elderly smokers had lower antibody titers than control. There was no significant association between antibody titer and severity in HDP.